Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today the opening of its cutting-edge Center of ...
Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc.  ("Revance"), today announced that the tender offer to purchase all of the issued and outstanding shares of common stock, par value $0 ...
YAMAGATA, Japan, Feb. 3, 2025 /PRNewswire/ — Spiber, a pioneer in protein fibers (ISO 2076) produced using fermentation ...
The Les Paul Standards displayed at the 1955 NAMM Show were the first to ever be fitted with no-wire ABR-1 Tune-O-Matic bridges and Stop Bar tailpieces, and were graced with unique custom finishes ...
Dylan Trotter is in no rush to open a restaurant in his father’s space along Armitage Avenue as Grant Achatz’s pop-up brings ...
Lexmark, a global imaging and IoT solutions leader, today announced significant additions to two of its core print offerings: three new models for its landmark 9-Series line of printers and ...
So take a moment to sympathize with the long term shareholders of Molecular Partners AG (VTX:MOLN), who have seen the share price tank a massive 81% over a three year period. That'd be enough to ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...
But you want to avoid the really big losses like the plague. So take a moment to sympathize with the long term shareholders of Molecular Partners AG (VTX:MOLN), who have seen the share price tank a ...
Dec. 17, 2024 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin ...
J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...
and PARIS, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class ...